Navigation Links
Sticky protein helps reinforce fragile muscle membranes
Date:7/23/2009

king with a mouse model of these diseases, the researchers, including Renzhi Han, Ph.D., a UI research scientist and the first author of the study, found that injecting functional dystroglycan into muscle that lacks this component restored muscle membrane integrity and protected the muscles from damage.

"Injecting the protein helped us prove that glycosylated dystroglycan is required to attach the membrane to the extracellular proteins and thus reinforce the membrane integrity," said Campbell, who also holds the Roy J. Carver Chair of Physiology and Biophysics. "However, this tool also suggests that delivering functional dystroglycan to muscles may be a possible therapeutic approach for treating these muscular dystrophies."

Another experiment, which also confirmed the role of glycosylated dystroglycan in binding the membrane and the basal lamina, also may have clinical implications.

The team showed that a virus called LCMV (Lymphocytic Choriomeningitis virus), which binds tightly to alpha dystroglycan, also disrupts the basal lamina muscle membrane interaction and compromises the integrity of the muscle membranes. LCMV is a member of a group of viruses that can cause hemorrhagic diseases. The study suggests that these viruses disrupt the dystroglycan basal lamina interaction, rendering the cell membrane susceptible to rupture.

"Considering how essential cell membranes are for life, these barriers are remarkably fragile. In addition, many tissues, including muscle, GI tract and skin, are constantly under mechanical stress, which can rupture cell membranes," Campbell said. "Our findings support the idea that reinforcement of the membrane basal lamina attachment is a basic cellular mechanism that allows cell survival in tissues subjected to mechanical stress."


'/>"/>

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-356-7124
University of Iowa
Source:Eurekalert  

Page: 1 2

Related biology news :

1. A sticky business -- how cancer cells become more gloopy as they die
2. As sticky as a gecko... but 10 times stronger!
3. Sticky questions tackled in gecko research
4. Plant protein doorkeepers block invading microbes, study finds
5. Protein can help cells or cause cancer, Purdue researcher finds
6. Plant protein doorkeepers block invading microbes, study finds
7. Structural biology scores with protein snapshot
8. Proteins in gel
9. Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease
10. Researchers observe single protein dimers wavering between two symmetrically opposed structures
11. Cancer-causing protein can also help fight the tumors it causes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sticky protein helps reinforce fragile muscle membranes
(Date:7/11/2014)... and Mineral Research awarded Michael F. Holick, PhD, MD, ... 2014 Louis V. Avioli Award. Holick, a professor of ... for revolutionizing the understanding of vitamin D and its ... a member of the American Society for Bone and ... mineral basic research. It is named for ASBMR,s first ...
(Date:7/11/2014)... The Chinese University of Hong Kong, BGI and other ... to salt tolerance, with implication for improving this important ... online in Nature Communications provides an effective ... , Soybean is an important crop for the world. ... less genetic diversities than their wild counterparts. Among the ...
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2BGI reports a novel gene for salt tolerance found in wild soybean 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... PITTSBURGH, Jan. 3 Mice bred to age too quickly ... scientists at the University of Pittsburgh School of Medicine injected ... of young, healthy animals. Instead of becoming infirm and dying ... cells improved their health and lived two to three times ...
... line of attack against pancreatitis and pancreatic cancer is ... substantial new funding from the Medical Research Council (MRC). ... digestion turn on the pancreas itself. Chronic pancreatitis increases ... five-year survival rate of all common cancers in the ...
... kind, researchers at Queens College and Mount Sinai School ... and maternal gestational diabetes together may cause a 14-fold ... six year olds. The data are published in the ... Adolescent Medicine , one of the JAMA/Archives journals. ...
Cached Biology News:Pitt: A shot of young stem cells made rapidly aging mice live longer and healthier 2New stage in fighting pancreatic cancer 2Gestational diabetes and low socioeconomic status raise risk of ADHD in children 2
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
(Date:7/10/2014)... July 10, 2014 Terascala, the industry ... that Alan Swahn, a former vice president of product ... as vice president of marketing. Terascala’s software when combined ... NetApp create the highest performance and most reliable solutions ... to guide Terascala’s channel expansion and broaden its product ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Robert Harman, ... Veterinary Medicine company, is proud to announce the relaunch of ... launching with a new series called “ What are Stem ... give an honest and straightforward foundation in the basics of ... educated decision on the right type of treatment when considering ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 EvoDerma ’s ... convenience. This rejuvenating device now comes with a second treatment ... over time. , The new cup is thinner on the ... works to target rough, thin and uneven surfaces on the ... cup for a stimulating treatment on areas such as the ...
Breaking Biology Technology:DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... Safety, Proof of Mechanism of a Potential Oral Antagonist ... 20 Amira Pharmaceuticals, Inc., announced today the initiation ... internally discovered oral drug candidate for the treatment and ... arachidonic acid pathway.AM211 is an oral, selective antagonist of ...
... (Nasdaq: BNVI ) today announced the poster presentation ... compound and mechanism of action for its preclinical cancer drug ... conference of the American Association of Cancer Research (AACR) in ... , BN108, ...
... Group of AdvisorsSAN DIEGO, April 20 Trius Therapeutics, ... Board, naming Donald H. Batts, MD, FACP, FIDSA, and ... members of the group of anti-infective thought leaders. ... Michigan State University and the Chief of Infectious ...
Cached Biology Technology:Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist 2Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 2Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 3Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2